Table 1.
Manipulation of Wnt/β-Catenin Pathway | Injury Model | Response | Mechanism | Ref. |
---|---|---|---|---|
Deletion of Wnt7 in macrophages | I/R | Increased renal tubular apoptosis | Cell cycle progression and basement membrane repair | [32] |
Tubule specific ablation of β-catenin | I/R and folic acid | Greater mortality and tubular apoptosis, lower renal function | Increased pro-apototic Bax and p53, decreased pAkt and survivin | [33] |
GSK-3β inhibition in proximal tubule | HgCl2 | Reduced tubular apoptosis and mortality, improved function | Increased cell proliferation and cyclin D1/c-Myc | [35] |
Wnt1 overexpression by proximal tubule | None | Increased interstitial fibrosis | Increased paracrine myofibroblast signaling, no epithelial injury | [38] |
Tubule specific ablation of β-catenin | UUO | No effect on fibrosis, reduced epithelial de-differentiation, increased fibroblast survival | Fibroblast survival due to reduced MMP-7-dependent FasL induction | [39] |
Proximal tubule specific β-catenin stabilization (cells also lack TGF-β receptor) | Aristolochic acid | Reduced tubulointerstitial fibrosis, improved renal function, and reduced tubular injury | Reduced susceptibility to apoptosis and decreased G2/M arrest | [40] |
Mutation of Frizzled4 receptor, primarily expressed in epithelia | I/R | Persistent epithelial injury | Increased apoptosis | [32] |
I/R: ischemia/reperfusion; GSK: glycogen sythase kinase; UUO: unilateral ureteral obstruction; MMP-7: matrix metalloproteinase-7; TGF-β: transforming growth factor-β.